Clinical snapshot — for veterinary teams
- Class: PDE5 inhibitor (Viagra); off-label drug of choice for canine pulmonary hypertension (also used for megaesophagus); pulmonary-artery vasodilation via ↑cGMP
- Dosing: ~1–3 mg/kg PO q8–12h — short-acting, so consistent timing matters; give on an empty stomach (~1 h before / 2 h after food); often compounded (liquid) and can be expensive
- What improvement looks like: better exercise tolerance, less cough, fewer syncope (fainting) episodes, improved quality of life — response is variable
- Counsel clients on: generally well tolerated; occasional GI upset (vomiting, diarrhea, appetite); possible hypotension (vasodilator)
- The caveat: treats the pulmonary pressure, not the underlying disease (chronic lung/heart disease, heartworm) — that must be managed too
Plain answer for owners who landed here: Sildenafil — yes, the same drug as Viagra — is the main medication for pulmonary hypertension (high blood pressure in the lungs) in dogs. It relaxes the lung’s blood vessels, which can make a real difference: dogs often breathe easier, cough less, faint less, and tolerate activity better. Because it’s short-acting, give it consistently (usually 2–3 times a day) on an empty stomach. The best way to know it’s working is to watch your dog’s energy, breathing, coughing, and any fainting — those are what improve. It controls the lung pressure but doesn’t cure the underlying heart or lung problem, so keep managing that with your vet.
What it’s used for — and why follow-up matters
Sildenafil is the cornerstone of canine pulmonary-hypertension management, and its follow-up profile is symptom-tracking-defined. Owners can’t see pulmonary-artery pressure — what they can see, and what actually defines benefit, is exercise tolerance, cough frequency, breathing effort, and syncope episodes. Because response is variable and these are serious patients (often older small-breed dogs with significant comorbidity), structured tracking of those clinical signs is how the clinic knows whether to continue, adjust, or escalate. Add the consistent short-acting dosing, the empty-stomach requirement, the cost/compounding logistics, and the underlying-disease caveat, and a short follow-up does real clinical work.
The adverse-event and monitoring profile
Per veterinary cardiology references, sildenafil is a short-acting PDE5 inhibitor that vasodilates pulmonary vessels (raising cGMP), shown to lower pulmonary arterial pressure, improve quality of life, and improve survival in canine pulmonary hypertension — it’s considered the drug of choice, dosed ~1–3 mg/kg PO q8–12h on an empty stomach. It’s generally well tolerated with rare GI effects (vomiting, diarrhea, reduced appetite); as a vasodilator, hypotension is possible. Response is variable, and the meaningful outcomes are clinical — syncope, cough, exercise tolerance, breathing, and owner-assessed quality of life (with echocardiographic pressure gradients and NT-proBNP tracked by the clinic). It’s frequently compounded and can be relatively expensive but affordable for many clients. Crucially, it manages the pulmonary pressure but the underlying cardiopulmonary disease must also be treated. (Sources: How I Treat: Pulmonary Hypertension — WSAVA/VIN; Sildenafil for dogs — GoodRx; Clinical features/outcome of sildenafil-treated PH — JVIM.)
The follow-up window that matters
The first month is pivotal — clinical signs (exercise tolerance, cough, syncope, breathing) often improve within weeks, and this window establishes whether the dog is responding. Ongoing, follow-up tracks those same signs, adherence to the consistent q8–12h empty-stomach schedule, and management of the underlying disease.
What to ask clients at follow-up
A symptom-and-adherence check:
- How is your dog’s energy and breathing — and any fainting episodes or coughing? (the real markers of benefit)
- Are you giving it consistently (every 8–12 hours) on an empty stomach?
- Any vomiting, diarrhea, or appetite change?
- Is the underlying heart/lung condition still being managed?
The exercise/cough/syncope questions are the ones that tell the clinic whether the drug is working.
Where compliance breaks down
The defining issues are inconsistent dosing of a short-acting drug (gaps in pulmonary vasodilation), giving it with food (reduced absorption), cost-driven lapses, and not tracking the clinical signs that signal response or deterioration. All are follow-up gaps a structured check resolves.
Standardizing this follow-up without adding staff time
This is a strong fit for Nidana Loop. After sildenafil is prescribed, Loop calls or texts to track the clinical markers that matter (exercise tolerance, cough, syncope, breathing), reinforce consistent empty-stomach dosing, screen for GI effects, and keep the underlying-disease plan in view — returning it as a structured note and flagging deterioration or non-response to a vet. A variable-response drug in a fragile patient gets real symptom surveillance between rechecks, with no staff calls.
See Loop handle medication follow-up
Loop runs your clinical-sign tracking and dosing-adherence check automatically — returning structured outcomes to the clinic. Book a 20-minute demo → · See how Loop works →
For pet owners
What is sildenafil for in dogs? It’s the main treatment for pulmonary hypertension (high blood pressure in the lungs), helping dogs breathe easier, cough less, and faint less.
How should I give it? Consistently — usually 2–3 times a day — on an empty stomach (about an hour before or two hours after food).
How will I know it’s working? Watch your dog’s energy, breathing, coughing, and any fainting — those are what improve.
Does it cure the problem? No — it controls the lung pressure, but the underlying heart or lung disease still needs to be managed.
This article is general information, not veterinary advice. Owners should consult their veterinarian and follow the prescribed dosing schedule.
Sources: How I Treat: Pulmonary Hypertension — WSAVA/VIN; Sildenafil for dogs — GoodRx; Sildenafil-treated pulmonary hypertension outcomes — JVIM.